Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Ewa Piotrowicz , Ryszard Piotrowicz Added: 3 years ago
Telemedicine (TM) (see Table 1) finds its application most commonly in chronic heart failure (HF).1–3 TM can be useful during exercise training (ET) as a tool to control stability of the clinical status of patients and to supervise training sessions. These goals can be achieved by monitoring clinical symptoms (dyspnoea, fatigue, oedema, chest pain, palpitations, etc.) and monitoring parameters … View more

Heart Failure

Digital Health
Author(s): Miguel Mendes Added: 3 years ago
As far as I know, the designation ‘optimal medical treatment’ was first used by the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial1 investigators as a synonym for the state-of-the-art measures encompassing drug regime, diet and physical activity recommended by the US guidelines for stable angina and acute coronary syndrome (ACS). Looking at the most… View more

Heart Failure

Prevention & Chronic Conditions
Maurizio Volterrani
Job title: Head of the Cardiological Rehabilitation Unit
Full Professor in of Exercise Science and Medicine at San Raffaele Telematic University of Rome. Head of the Cardiac Pulmonary Department at IRCCS San Raffaele in Rome. Prof Volterrani’s main research interests include heart failure, exercise training in cardiac rehabilitation, telemedicine, hyperkalaemia and kidney failure . He is and has been principal investigator in multiple international… View more
Research Area(s) / Expertise: Job title: Reader in Cardiovascular Physiology
Personal History Dr Jamie O'Driscoll is based in Canterbury, UK where he holds the position of Reader in Cardiovascular Physiology at Canterbury Christ Church University. Academic History Dr Jamie O'Driscoll, BSc (Hons), MSc (Hons), CertEd, PhD, graduated with a 1st class honours in Sport Science from Brunel University, where he went on to earn a distinction in his MSc in Health and… View more
Author(s): Hugo Saner Added: 3 years ago
Coronary heart disease (CHD) is the leading cause of death in most countries. It is also a major cause of physical disability, particularly in the rapidly growing population of elderly people. The prevention of subsequent coronary events and the maintenance of physical functioning in such patients are major challenges in preventative care. Cardiac rehabilitation (CR) programmes were first… View more

Prevention & Chronic Conditions

MI/ACS
Author(s): Hugo Saner Added: 3 years ago
Coronary heart disease (CHD) is the leading cause of death in most countries. It is also a major cause of physical disability, particularly in the rapidly growing population of elderly people. The prevention of subsequent coronary events and the maintenance of physical functioning in such patients are major challenges in preventative care. Cardiac rehabilitation (CR) programmes were first… View more

Prevention & Chronic Conditions

Heterogeneous Populations
ISCP: A to Z of CV Pharmacotherapy Webinar Series
Author(s): Sotiris Antoniou , Bernard Man Yung Cheung , Krzysztof Filipiak , et al Added: 1 year ago
TheInternational Society of Cardiovascular Pharmacotherapy (ISCP) are pleased to present a collection of six webinars as part of their A to Z of Pharmacotherapy Series. Published every other month until Dec 2022, these 60-min webinars feature expert panellists, speakers and moderators with live Q&A audiences and EBAC accreditation (1 CME point) for all live views. This series is ideal… View more

Anticoagulation

Standards & Guidelines
Non-pharmacological Management and Patient Education in HF Patients
Author(s): Tiny Jaarsma Added: 3 years ago
Heart failure (HF) has become a significant public health problem, with a rapidly rising incidence and prevalence that is predicted to continue to rise far into the 21st century.1 Overall, 1-2% of the adult population in developed countries worldwide suffers from HF but prevalence increases 10-fold in those over 75 years of age.2 Because the incidence of HF rises with age its prevalence will… View more

Heart Failure
Ferric Carboxymaltose: Ironing Out the Issues Around HF Related Readmission
Author(s): David Sim , Maurizio Volterrani , Daniel Lighezan , et al Start date: Apr 13, 2022

Heart Failure
Clinical Management of Non-alcoholic Steatohepatitis
Author(s): Carlos Millán-Rodríguez , Carlos Palacios Castelló , María de Regla Caballero-Valderrama , et al Added: 3 months ago

Prevention & Chronic Conditions